ANCA-associated Vasculitis Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Systemic Lupus ErythematosusSjogren SyndromeInflammatory Myopathy+6 more
Peking University People's Hospital50 enrolled1 locationNCT06794008
Recruiting
Phase 4
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Maintenance TherapyANCA-associated Vasculitis
Chinese SLE Treatment And Research Group40 enrolled1 locationNCT05965284